Literature DB >> 26525545

Recent highlights of experimental research for inhibiting tumor growth by using Chinese medicine.

Xi-ran He1, Shu-yan Han1, Ping-ping Li2.   

Abstract

To give an overview of contemporary experimental research using Chinese medicine (CM) for the treatment of cancer. As an integral part of mainstream medicine in the People's Republic of China, CM emphasizes improvements in holistic physical condition instead of merely killing tumor cells, which is consistent with the current medical model that advocates patient-oriented treatment. Great progress has been made in experimental research, and the principle aspects include anti-tumor angiogenesis, inducing apoptosis and differentiation, reversing multidrug resistance, and improving immune function. As a current hot topic in cancer research, tumor microenvironment (TME) highlights the mutual and interdependent interaction between tumor cells and their surrounding tissues, and the CM treatment concept bears a striking resemblance to it. To date, primary points of TME include extracellular matrix remodeling, inflammation, hypoxia, and angiogenesis, but trials using CM with a focus on TME are rare. Despite considerable recent development, experimental research on CM for solving cancer issues appears insufficient. Greater efforts in this field are urgently needed.

Entities:  

Keywords:  Chinese medicine; experimental research; highlights; tumor

Mesh:

Substances:

Year:  2015        PMID: 26525545     DOI: 10.1007/s11655-015-2318-8

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  44 in total

1.  Marsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cells.

Authors:  Shu-Yan Han; Ming-Bo Zhao; Gui-Bao Zhuang; Ping-Ping Li
Journal:  Lung Cancer       Date:  2011-07-16       Impact factor: 5.705

2.  In vitro antimetastatic effect of Changweiqing through antiinvasion of hypoxic colorectal carcinoma LoVo cells.

Authors:  Jing Li; Zhong-Ze Fan; Jue Sun; Jian-Hua Xu
Journal:  Chin J Integr Med       Date:  2011-07-03       Impact factor: 1.978

3.  Immuno-enhancement effects of Shenqi Fuzheng Injection on cyclophosphamide-induced immunosuppression in Balb/c mice.

Authors:  Jinxu Wang; Xin Tong; Peibo Li; Hui Cao; Weiwei Su
Journal:  J Ethnopharmacol       Date:  2011-12-27       Impact factor: 4.360

4.  Effects of Jianpi Jiedu Recipe on reversion of P-glycoprotein-mediated multidrug resistance through COX-2 pathway in colorectal cancer.

Authors:  Hua Sui; Hui-rong Zhu; Jie Wu; Alexander Yu Nikitin; Jian-feng Cai; Zhong-ze Fan; Qi Li
Journal:  Chin J Integr Med       Date:  2013-04-01       Impact factor: 1.978

5.  Effects of taohong siwu decoction II in the chick chorioallantoic membrane (CAM) assay and on B16 melanoma in mice and endothelial cells ECV304 proliferation.

Authors:  Xiaoyu Xu; Shumei Wang; Weihai Chen; Gang Chen
Journal:  J Tradit Chin Med       Date:  2006-03       Impact factor: 0.848

Review 6.  Disrupting proton dynamics and energy metabolism for cancer therapy.

Authors:  Scott K Parks; Johanna Chiche; Jacques Pouysségur
Journal:  Nat Rev Cancer       Date:  2013-09       Impact factor: 60.716

7.  Erxian decoction, a traditional chinese herbal formula, inhibits angiogenesis in human umbilical vein endothelial cells.

Authors:  Xiaobin Yu; Yao Tong; Weihuan Huang; Wei Ge
Journal:  Biol Pharm Bull       Date:  2013-02-07       Impact factor: 2.233

8.  Anti-angiogenic and antitumor activities of Huaier aqueous extract.

Authors:  Xiaolong Wang; Ning Zhang; Qiang Huo; Qifeng Yang
Journal:  Oncol Rep       Date:  2012-08-08       Impact factor: 3.906

9.  Immunomodulatory and antitumour effects of abnormal Savda Munziq on S180 tumour-bearing mice.

Authors:  Ainiwaer Aikemu; Anwar Umar; Abdiryim Yusup; Halmurat Upur; Bénédicte Berké; Bernard Bégaud; Nicholas Moore
Journal:  BMC Complement Altern Med       Date:  2012-09-17       Impact factor: 3.659

10.  Teng-Long-Bu-Zhong-Tang, a Chinese herbal formula, enhances anticancer effects of 5--Fluorouracil in CT26 colon carcinoma.

Authors:  Shan Deng; Bing Hu; Hong-Mei An; Qin Du; Ling Xu; Ke-Ping Shen; Xiu-Feng Shi; Meng-Meng Wei; Yang Wu
Journal:  BMC Complement Altern Med       Date:  2013-06-08       Impact factor: 3.659

View more
  3 in total

Review 1.  Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology.

Authors:  Jianbo Zhou; Li Wang; Cheng Peng; Fu Peng
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

Review 2.  Anti-Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms.

Authors:  Weilin Zheng; Lixing Cao; Zheng Xu; Yuanyuan Ma; Xuefang Liang
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-01       Impact factor: 2.629

3.  Clinical study on postoperative triple-negative breast cancer with Chinese medicine: Study protocol for an observational cohort trial.

Authors:  Jiajing Chen; Yuenong Qin; Chenping Sun; Wei Hao; Shuai Zhang; Yi Wang; Juan Chen; Lixin Chen; Yiying Ruan; Sheng Liu
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.